Cargando…

COVID-19 vaccinology landscape in Africa

More than two years after the start of COVID-19 pandemic, Africa still lags behind in terms vaccine distribution. This highlights the predicament of Africa in terms of vaccine development, deployment, and sustainability, not only for COVID-19, but for other major infectious diseases that plague the...

Descripción completa

Detalles Bibliográficos
Autores principales: Baptista, Sara, Naidoo, Sanushka, Suliman, Sara, Nepolo, Emmanuel, Kanoi, Bernard N., Gitaka, Jesse, Blessing, Oyedemi Mbaebie, Enany, Shymaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760752/
https://www.ncbi.nlm.nih.gov/pubmed/36544758
http://dx.doi.org/10.3389/fimmu.2022.955168
_version_ 1784852549137858560
author Baptista, Sara
Naidoo, Sanushka
Suliman, Sara
Nepolo, Emmanuel
Kanoi, Bernard N.
Gitaka, Jesse
Blessing, Oyedemi Mbaebie
Enany, Shymaa
author_facet Baptista, Sara
Naidoo, Sanushka
Suliman, Sara
Nepolo, Emmanuel
Kanoi, Bernard N.
Gitaka, Jesse
Blessing, Oyedemi Mbaebie
Enany, Shymaa
author_sort Baptista, Sara
collection PubMed
description More than two years after the start of COVID-19 pandemic, Africa still lags behind in terms vaccine distribution. This highlights the predicament of Africa in terms of vaccine development, deployment, and sustainability, not only for COVID-19, but for other major infectious diseases that plague the continent. This opinion discusses the challenges Africa faces in its race to vaccinate its people, and offers recommendations on the way forward. Specifically, to get out of the ongoing vaccine shortage trap, Africa needs to diversify investment not only to COVID-19 but also other diseases that burden the population. The continent needs to increase its capacity to acquire vaccines more equitably, improve access to technologies to enable local manufacture of vaccines, increase awareness on vaccines both in rural and urban areas to significantly reduce disease incidence of COVID-19 and as well as other prevalent diseases on the African continent such as HIV and TB. Such efforts will go a long way to reduce the disease burden in Africa.
format Online
Article
Text
id pubmed-9760752
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97607522022-12-20 COVID-19 vaccinology landscape in Africa Baptista, Sara Naidoo, Sanushka Suliman, Sara Nepolo, Emmanuel Kanoi, Bernard N. Gitaka, Jesse Blessing, Oyedemi Mbaebie Enany, Shymaa Front Immunol Immunology More than two years after the start of COVID-19 pandemic, Africa still lags behind in terms vaccine distribution. This highlights the predicament of Africa in terms of vaccine development, deployment, and sustainability, not only for COVID-19, but for other major infectious diseases that plague the continent. This opinion discusses the challenges Africa faces in its race to vaccinate its people, and offers recommendations on the way forward. Specifically, to get out of the ongoing vaccine shortage trap, Africa needs to diversify investment not only to COVID-19 but also other diseases that burden the population. The continent needs to increase its capacity to acquire vaccines more equitably, improve access to technologies to enable local manufacture of vaccines, increase awareness on vaccines both in rural and urban areas to significantly reduce disease incidence of COVID-19 and as well as other prevalent diseases on the African continent such as HIV and TB. Such efforts will go a long way to reduce the disease burden in Africa. Frontiers Media S.A. 2022-12-05 /pmc/articles/PMC9760752/ /pubmed/36544758 http://dx.doi.org/10.3389/fimmu.2022.955168 Text en Copyright © 2022 Baptista, Naidoo, Suliman, Nepolo, Kanoi, Gitaka, Blessing and Enany https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Baptista, Sara
Naidoo, Sanushka
Suliman, Sara
Nepolo, Emmanuel
Kanoi, Bernard N.
Gitaka, Jesse
Blessing, Oyedemi Mbaebie
Enany, Shymaa
COVID-19 vaccinology landscape in Africa
title COVID-19 vaccinology landscape in Africa
title_full COVID-19 vaccinology landscape in Africa
title_fullStr COVID-19 vaccinology landscape in Africa
title_full_unstemmed COVID-19 vaccinology landscape in Africa
title_short COVID-19 vaccinology landscape in Africa
title_sort covid-19 vaccinology landscape in africa
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760752/
https://www.ncbi.nlm.nih.gov/pubmed/36544758
http://dx.doi.org/10.3389/fimmu.2022.955168
work_keys_str_mv AT baptistasara covid19vaccinologylandscapeinafrica
AT naidoosanushka covid19vaccinologylandscapeinafrica
AT sulimansara covid19vaccinologylandscapeinafrica
AT nepoloemmanuel covid19vaccinologylandscapeinafrica
AT kanoibernardn covid19vaccinologylandscapeinafrica
AT gitakajesse covid19vaccinologylandscapeinafrica
AT blessingoyedemimbaebie covid19vaccinologylandscapeinafrica
AT enanyshymaa covid19vaccinologylandscapeinafrica